Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Perrigo Gets "Wake-Up Call" In FDA Warning Letter

This article was originally published in The Tan Sheet

Executive Summary

Perrigo prioritized correcting manufacturing problems that drew an FDA warning, advising the firm to prevent human errors with tighter quality control, according to CEO Joseph Papa
Advertisement

Related Content

Perrigo Sales Reach Record Highs Despite Manufacturing Restrictions
Perrigo Sales Reach Record Highs Despite Manufacturing Restrictions
Perrigo Sales Reach Record Highs Despite Manufacturing Restrictions
Rolaids Recall Puts Contract Manufacturers In Issa's Crosshairs
Rolaids Recall Puts Contract Manufacturers In Issa's Crosshairs
Rolaids Recall Puts Contract Manufacturers In Issa's Crosshairs
Novartis Extends Triaminic Into Brand Name Void Left By J&J Tylenol Recall
Chart: PLMA Paints Picture Of Persistent Private Label Penetration
Perrigo Targets October For Quality System Corrections, FDA Re-Inspection
Recall Stifles J&J's Consumer Product Sales Growth

Topics

Advertisement
UsernamePublicRestriction

Register

PS104161

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel